Page 49 - Read Online
P. 49
Page 10 of 10 Rath et al. J Cancer Metastasis Treat 2020;6:30 I http://dx.doi.org/10.20517/2394-4722.2020.51
tumor growth via osteopontin. FASEB J 2019;33:114-25.
26. Ramchandani D, Weber GF. Interactions between osteopontin and vascular endothelial growth factor: implications for cancer. Biochim
Biophys Acta 2015;1855:202-22.
27. BandopadhyayM, Bulbule A, Butti R, Chakraborty G, Ghorpade P, et al. Osteopontin as a therapeutic target for cancer. Expert OpinTher
Targets 2014;18:883-95.
28. Kale S, Raja R, Thorat D, Soundararajan G, Patil TV, et al. Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-
associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin. Oncogene 2014;33:2295-306.
29. Weigert A, Mora J, Sekar D, Syed S, Brüne B. Killing is not enough: how apoptosis hijacks tumor-associated macrophages to promote
cancer progression. AdvExp Med Biol 2016;930:205-39.
30. De Jong JS, van Diest PJ, Baak JP. Number of apoptotic cells as a prognostic marker in invasive breast cancer. Br J Cancer
2000;82:368-73.
31. Gregory CD, Pound JD. Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues.
J Pathol 2011;223:177-94.
